Clinical Trials Logo

Clinical Trial Summary

The investigators propose that brief training in regulation of craving may increase the efficacy of smoking cessation, but that training in cognitive vs. mindfulness-based strategies may operate via different psychological and neural mechanisms.


Clinical Trial Description

The investigators propose to test the efficacy of such training by randomizing 126 cigarette smokers to the following conditions: 1) brief training in cognitive regulation of craving 2) mindfulness-based training, and 3) control or no training. Training will be delivered in 6x1 hour computerized sessions over four weeks. Control subjects simply fill out assessments during their visits. Participants who were randomized into the cognitive or mindfulness training complete Regulation of Craving (ROC) training sessions of approximately 60-90 minutes. If randomized into the cognitive regulation training, subjects will be trained to use a cognitive strategy that instructs them to think of all the negative outcomes associated with continued cigarette smoking. If randomized into the MBT-based regulation training, subjects will be trained to use a mindfulness strategy that instructs them to notice and accept their feelings of craving without judgment or intent to act upon them. After all training sessions are completed, there is a 4 week and 12 week follow-up. The investigators will evaluate the effects of training on craving and regulation of craving measured by self-report and functional magnetic resonance imaging during the Regulation of Craving(ROC) task administered pre- and post- treatment, as well as smoking. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02153749
Study type Interventional
Source Yale University
Contact
Status Completed
Phase N/A
Start date September 2015
Completion date July 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02643914 - Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings N/A
Recruiting NCT05530577 - Effects of Semaglutide on Nicotine Intake Phase 2
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT01944423 - Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine Early Phase 1
Completed NCT01704573 - Nicotinic Receptor Levels After Stopping Smoking N/A
Active, not recruiting NCT01015170 - STOP Study: Effectiveness of Zyban in a Clinical Population Phase 4
Completed NCT03281629 - Circuitry-Guided Smoking Cessation in Schizophrenia N/A
Recruiting NCT06291584 - Effects of Exercises on Functional Capacity N/A
Withdrawn NCT06259630 - Nicotine Virtual Reality Conditioned Place Preference Phase 4
Completed NCT02624284 - tDCS Effects on Resisting Smoking: Dose Ranging Study N/A
Active, not recruiting NCT02837510 - Neural Mechanisms Associated With Risk of Smoking Relapse N/A
Completed NCT02656745 - Clinical Trial of Smoking Cessation Mobile Phone Program N/A
Completed NCT01062932 - Investigation of Cycloserine as a Smoking Cessation Treatment Phase 1
Completed NCT03069482 - Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness Phase 1
Completed NCT02870218 - Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use Phase 2
Terminated NCT01756053 - Effects of ABT-089 on Smoking Abstinence Symptoms and Reward Phase 2
Completed NCT01252966 - Cognitive Training for Nicotine Dependence N/A
Active, not recruiting NCT04946825 - Quit Smoking Study for People Who Use E-Cigarettes Phase 2
Recruiting NCT05434429 - Mobile Health for Problematic Behaviors and Substance Use N/A